Published Date：Mar.2021
Industry：Chemical & Material
Pages：119 Table Number：132
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Receptor Tyrosine Protein Kinase Targeted Drugs market in this environment. In terms of revenue, this research report indicated that the global Receptor Tyrosine Protein Kinase Targeted Drugs market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Receptor Tyrosine Protein Kinase Targeted Drugs industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The Aslan Pharmaceuticals aims at producing XX K Units Receptor Tyrosine Protein Kinase Targeted Drugs in 2020, with XX % production to take place in global market, Boehringer Ingelheim accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Receptor Tyrosine Protein Kinase Targeted Drugs Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Receptor Tyrosine Protein Kinase Targeted Drugs Market? Aslan Pharmaceuticals Boehringer Ingelheim GamaMabs Pharma Hanmi Pharmaceuticals Jiangsu Kanion Pharmaceutical Minerva Neurosciences Pfizer Puma Biotechnology Shanghai Fosun Pharmaceutical (Group) XuanZhu Pharma Zensun (Shanghai) Sci and Tech ... Major Type of Receptor Tyrosine Protein Kinase Targeted Drugs Covered in XYZResearch report: Afatinib Dimaleate Dacomitinib Neratinib Neucardin Others Application Segments Covered in XYZResearch Market Oncology Cardiovascular Central Nervous System Others For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Afatinib Dimaleate -Product Introduction and Major Manufacturers 1.1.2 Dacomitinib -Product Introduction and Major Manufacturers 1.1.3 Neratinib -Product Introduction and Major Manufacturers 1.1.4 Neucardin -Product Introduction and Major Manufacturers 1.1.5 Others -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027) 2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027) 3 Regional Market Analysis 3.1 China Receptor Tyrosine Protein Kinase Targeted Drugs Market 3.1.1 Top Companies leading Receptor Tyrosine Protein Kinase Targeted Drugs Development in China (2016-2021) 3.1.2 Sales Value of Major Company in China Market (2016-2021) 3.1.3 China Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2026-2027) 3.2 EU Receptor Tyrosine Protein Kinase Targeted Drugs Market 3.2.1 Top Companies leading Receptor Tyrosine Protein Kinase Targeted Drugs Development in EU (2016-2021) 3.2.2 Sales Value of Major Company in EU Market (2016-2021) 3.2.3 EU Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2026-2027) 3.3 USA Receptor Tyrosine Protein Kinase Targeted Drugs Market 3.3.1 Top Companies leading Receptor Tyrosine Protein Kinase Targeted Drugs Development in USA (2016-2021) 3.3.2 Sales Value of Major Company in USA Market (2016-2021) 3.3.3 USA Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2026-2027) 3.4 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Market 3.4.1 Top Companies leading Receptor Tyrosine Protein Kinase Targeted Drugs Development in Japan (2016-2021) 3.4.2 Sales Value of Major Company in Japan Market (2016-2021) 3.4.3 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2026-2027) 3.5 India Receptor Tyrosine Protein Kinase Targeted Drugs Market 3.5.1 Top Companies leading Receptor Tyrosine Protein Kinase Targeted Drugs Development in India (2016-2021) 3.5.2 Sales Value of Major Company in India Market (2016-2021) 3.5.3 India Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2026-2027) 3.6 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Market 3.6.1 Top Companies leading Receptor Tyrosine Protein Kinase Targeted Drugs Development in Southeast Asia (2016-2021) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021) 3.6.3 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2026-2027) 3.7 South America Receptor Tyrosine Protein Kinase Targeted Drugs Market 3.7.1 Top Companies leading Receptor Tyrosine Protein Kinase Targeted Drugs Development in South America (2016-2021) 3.7.2 Sales Value of Major Company in South America Market (2016-2021) 3.7.3 South America Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2026-2027) 4 Value Chain (Impact of COVID-19) 4.1 Receptor Tyrosine Protein Kinase Targeted Drugs Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Receptor Tyrosine Protein Kinase Targeted Drugs Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2027) 5.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Growth Rate (2021-2027) 5.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value and Growth Rate (2021-2027) 6 Receptor Tyrosine Protein Kinase Targeted Drugs Competitive Analysis 6.1 Aslan Pharmaceuticals 6.1.1 Aslan Pharmaceuticals Company Profiles 6.1.2 Aslan Pharmaceuticals Product Introduction 6.1.3 Aslan Pharmaceuticals Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue (2016-2021) 6.1.4 SWOT Analysis 6.2 Boehringer Ingelheim 6.2.1 Boehringer Ingelheim Company Profiles 6.2.2 Boehringer Ingelheim Product Introduction 6.2.3 Boehringer Ingelheim Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue (2016-2021) 6.2.4 SWOT Analysis 6.3 GamaMabs Pharma 6.3.1 GamaMabs Pharma Company Profiles 6.3.2 GamaMabs Pharma Product Introduction 6.3.3 GamaMabs Pharma Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue (2016-2021) 6.3.4 SWOT Analysis 6.4 Hanmi Pharmaceuticals 6.4.1 Hanmi Pharmaceuticals Company Profiles 6.4.2 Hanmi Pharmaceuticals Product Introduction 6.4.3 Hanmi Pharmaceuticals Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue (2016-2021) 6.4.4 SWOT Analysis 6.5 Jiangsu Kanion Pharmaceutical 6.5.1 Jiangsu Kanion Pharmaceutical Company Profiles 6.5.2 Jiangsu Kanion Pharmaceutical Product Introduction 6.5.3 Jiangsu Kanion Pharmaceutical Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue (2016-2021) 6.5.4 SWOT Analysis 6.6 Minerva Neurosciences 6.6.1 Minerva Neurosciences Company Profiles 6.6.2 Minerva Neurosciences Product Introduction 6.6.3 Minerva Neurosciences Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue (2016-2021) 6.6.4 SWOT Analysis 6.7 Pfizer 6.7.1 Pfizer Company Profiles 6.7.2 Pfizer Product Introduction 6.7.3 Pfizer Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue (2016-2021) 6.7.4 SWOT Analysis 6.8 Puma Biotechnology 6.8.1 Puma Biotechnology Company Profiles 6.8.2 Puma Biotechnology Product Introduction 6.8.3 Puma Biotechnology Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue (2016-2021) 6.8.4 SWOT Analysis 6.9 Shanghai Fosun Pharmaceutical (Group) 6.9.1 Shanghai Fosun Pharmaceutical (Group) Company Profiles 6.9.2 Shanghai Fosun Pharmaceutical (Group) Product Introduction 6.9.3 Shanghai Fosun Pharmaceutical (Group) Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue (2016-2021) 6.9.4 SWOT Analysis 6.10 XuanZhu Pharma 6.10.1 XuanZhu Pharma Company Profiles 6.10.2 XuanZhu Pharma Product Introduction 6.10.3 XuanZhu Pharma Receptor Tyrosine Protein Kinase Targeted Drugs Production, Revenue (2016-2021) 6.10.4 SWOT Analysis 6.11 Zensun (Shanghai) Sci and Tech 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2021) Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2027) Table CAGR in Terms of Production of Each Type (2026-2027) Table CAGR in Terms of Production of Each Application (2026-2027) Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit) by Type (2026-2027) Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit) and Growth Rate (2026-2027) Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share (%) by Type (2019 -2020) Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value (Million USD) by Type (2026-2027) Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value (Million USD) and Growth Rate (2026-2027) Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value Market Share (%) by Type (2019-2020) Table Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit) by Application (2026-2027) Table China Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit) of Major Company (2016-2021) Table China Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share of Major Company (2016-2021) Table China Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value (Million USD) of Major Company (2016-2021) Figure China Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value (Million USD) and Growth Rate (2016-2021) Table China Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value Share of Major Company (2016-2021) Table China Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Unit), by Type (2019-2020) Table China Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit) by Type (2026-2027) Figure China Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit) by Type (2026-2027) Table EU Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit) of Major Company (2016-2021) Table EU Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share of Major Company (2016-2021) Table EU Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value (Million USD) of Major Company (2016-2021) Figure EU Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value (Million USD) and Growth Rate (2016-2021) Table EU Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value Share of Major Company (2016-2021) Table EU Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Unit), by Type (2019-2020) Table EU Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit) by Type (2026-2027) Figure EU Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit) by Type (2026-2027) Table USA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit) of Major Company (2016-2021) Table USA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share of Major Company (2016-2021) Table USA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value (Million USD) of Major Company (2016-2021) Figure USA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value (Million USD) and Growth Rate (2016-2021) Table USA Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value Share of Major Company (2016-2021) Table USA Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Unit), by Type (2019-2020) Table USA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit) by Type (2026-2027) Figure USA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit) by Type (2026-2027) Table Japan Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit) of Major Company (2016-2021) Table Japan Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share of Major Company (2016-2021) Table Japan Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value (Million USD) of Major Company (2016-2021) Figure Japan Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value (Million USD) and Growth Rate (2016-2021) Table Japan Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value Share of Major Company (2016-2021) Table Japan Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Unit), by Type (2019-2020) Table Japan Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit) by Type (2026-2027) Figure Japan Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit) by Type (2026-2027) Table India Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit) of Major Company (2016-2021) Table India Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share of Major Company (2016-2021) Table India Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value (Million USD) of Major Company (2016-2021) Figure India Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value (Million USD) and Growth Rate (2016-2021) Table India Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value Share of Major Company (2016-2021) Table India Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Unit), by Type (2019-2020) Table India Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit) by Type (2026-2027) Figure India Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit) by Type (2026-2027) Table Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit) of Major Company (2016-2021) Table Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share of Major Company (2016-2021) Table Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value (Million USD) of Major Company (2016-2021) Figure Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value (Million USD) and Growth Rate (2016-2021) Table Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value Share of Major Company (2016-2021) Table Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit) by Type (2026-2027) Figure Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit) by Type (2026-2027) Table South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Unit) of Major Company (2016-2021) Table South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share of Major Company (2016-2021) Table South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value (Million USD) of Major Company (2016-2021) Figure South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value (Million USD) and Growth Rate (2016-2021) Table South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value Share of Major Company (2016-2021) Table South America Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Unit), by Type (2019-2020) Table South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit) by Type (2026-2027) Figure South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit) by Type (2026-2027) Figure Value Chain Structure of Receptor Tyrosine Protein Kinase Targeted Drugs Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Receptor Tyrosine Protein Kinase Targeted Drugs Figure Cost Structure of Receptor Tyrosine Protein Kinase Targeted Drugs in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2027) Table Regional Market Sales Share (2021-2027) Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit), Growth Rate & Market Share (2021-2027) Table Regional Market Sales Value (Million USD) (2021-2027) Table Regional Market Sales Value Share (2021-2027) Figure Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Value (Million USD), Growth Rate & Market Share (2021-2027) Table Aslan Pharmaceuticals Profiles Table Aslan Pharmaceuticals Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction Table Aslan Pharmaceuticals Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Aslan Pharmaceuticals SWOT Analysis Table Boehringer Ingelheim Profiles Table Boehringer Ingelheim Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction Table Boehringer Ingelheim Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Boehringer Ingelheim SWOT Analysis Table GamaMabs Pharma Profiles Table GamaMabs Pharma Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction Table GamaMabs Pharma Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure GamaMabs Pharma SWOT Analysis Table Hanmi Pharmaceuticals Profiles Table Hanmi Pharmaceuticals Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction Table Hanmi Pharmaceuticals Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Hanmi Pharmaceuticals SWOT Analysis Table Jiangsu Kanion Pharmaceutical Profiles Table Jiangsu Kanion Pharmaceutical Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction Table Jiangsu Kanion Pharmaceutical Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Jiangsu Kanion Pharmaceutical SWOT Analysis Table Minerva Neurosciences Profiles Table Minerva Neurosciences Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction Table Minerva Neurosciences Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Minerva Neurosciences SWOT Analysis Table Pfizer Profiles Table Pfizer Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction Table Pfizer Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Pfizer SWOT Analysis Table Puma Biotechnology Profiles Table Puma Biotechnology Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction Table Puma Biotechnology Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Puma Biotechnology SWOT Analysis Table Shanghai Fosun Pharmaceutical (Group) Profiles Table Shanghai Fosun Pharmaceutical (Group) Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction Table Shanghai Fosun Pharmaceutical (Group) Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Shanghai Fosun Pharmaceutical (Group) SWOT Analysis Table XuanZhu Pharma Profiles Table XuanZhu Pharma Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction Table XuanZhu Pharma Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure XuanZhu Pharma SWOT Analysis Table Zensun (Shanghai) Sci and Tech Profiles Table Zensun (Shanghai) Sci and Tech Receptor Tyrosine Protein Kinase Targeted Drugs Product Introduction Table Zensun (Shanghai) Sci and Tech Receptor Tyrosine Protein Kinase Targeted Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
